TrianglePUBLICATIONS · 16809734
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2006 Jul 1
- First author
- Small EJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Small EJ
- type
- Author
- name
- Schellhammer PF
- type
- Author
- name
- Higano CS
- type
- Author
- name
- Redfern CH
- type
- Author
- name
- Nemunaitis JJ
- type
- Author
- name
- Valone FH
- type
- Author
- name
- Verjee SS
- type
- Author
- name
- Jones LA
- type
- Author
- name
- Hershberg RM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Small EJ
- type
- Author
- name
- Schellhammer PF
- type
- Author
- name
- Higano CS
- type
- Author
- name
- Redfern CH
- type
- Author
- name
- Nemunaitis JJ
- type
- Author
- name
- Valone FH
- type
- Author
- name
- Verjee SS
- type
- Author
- name
- Jones LA
- type
- Author
- name
- Hershberg RM
- type
- Author
- bibliography ids
- nci-bib-54c75df8dff555a22a58b4cf
- book metadata
- content sha256
- ebfcd5e63512c27ac41b2dd78aa68c9516a77b0534ef962b277fcf4d4b8be472
- document type
- citation
- dois
- 10.1200/JCO.2005.04.5252
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16809734
- immutable id
- pubmed:16809734@ebfcd5e63512c27ac41b2dd78aa68c9516a77b0534ef962b277fcf4d4b8be472
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3089-94
- volume
- 24
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16809734
- provenance
- batch id
- 19fb2de9a00882c94e86
- provider
- NCBI PubMed ESummary
- record sha256
- 4db8a6879ee6210bdec1451c0a07f4fccf805de5a73e08dda5a587b2845389bb
- response sha256
- 4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
- retrieved at
- 2026-09-09T23:46:06.810486+00:00
- publication date
- display
- 2006 Jul 1
- precision
- day
- year
- 2006
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
Preserved source evidence · Not medical advice